{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:27:43Z","timestamp":1792981663359,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.placenta.2012.11.014","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T07:31:14Z","timestamp":1354951874000},"page":"201-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Eculizumab for the treatment of preeclampsia\/HELLP syndrome"],"prefix":"10.1016","volume":"34","author":[{"given":"R.M.","family":"Burwick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.B.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2012.11.014_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajog.2011.07.017","article-title":"Evaluation and management of severe preeclampsia before 34 weeks' gestation","volume":"205","author":"Publications Committee, Society for Maternal-Fetal Medicine","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2012.11.014_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1471-0528.1995.tb09062.x","article-title":"Temporising management of severe pre-eclampsia with and without the HELLP syndrome","volume":"102","author":"Visser","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.placenta.2012.11.014_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(97)00146-2","article-title":"Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome","volume":"76","author":"van Pampus","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.placenta.2012.11.014_bib4","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.placenta.2011.12.006","article-title":"Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia","volume":"33","author":"Redman","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2012.11.014_bib5","first-page":"19","article-title":"Complement, neutrophil, and macrophage activation in women with severe preeclampsia and syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"79","author":"Haeger","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.placenta.2012.11.014_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0897.2005.00362.x","article-title":"Preeclampsia: the death of Goliath","volume":"55","author":"Feinberg","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.placenta.2012.11.014_bib7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.AOG.0000258281.22296.de","article-title":"Imitators of severe preeclampsia","volume":"109","author":"Sibai","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.placenta.2012.11.014_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/plac.2002.0903","article-title":"Hypoxia favors necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation","volume":"24","author":"Huppertz","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2012.11.014_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.placenta.2012.11.014_bib10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the complement system in normal pregnancy and preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.placenta.2012.11.014_bib11","first-page":"209","article-title":"Complement activation in Brazilian patients with preeclampsia","volume":"10","author":"de Messias-Reason","year":"2000","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.placenta.2012.11.014_bib12","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.placenta.2012.11.014_bib13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.placenta.2008.07.008","article-title":"The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in\u00a0vivo and modulates human trophoblast function in\u00a0vitro","volume":"29","author":"Rampersad","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2012.11.014_bib14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","article-title":"Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv","volume":"33","author":"Thomas","year":"1996","journal-title":"Mol Immunol"},{"key":"10.1016\/j.placenta.2012.11.014_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2010.08099.x","article-title":"The management of pregnancy in paroxysmal nocturnal hemoglobinuria on long term eculizumab","volume":"149","author":"Kelly","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.placenta.2012.11.014_bib16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ajog.2005.08.044","article-title":"Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child","volume":"195","author":"Martin","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2012.11.014_bib17","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400412004493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400412004493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:47:18Z","timestamp":1758908838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400412004493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0143400412004493"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2012.11.014","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2012.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}